Applying EBITDA Multiples To Your Company Valuation
Thinking about selling your business? Learn how to apply Earnings Before Interest, Tax, Depreciation, and Amortization (EBTIDA) multiples to your company valuation.
You Haven’t Missed Out On The Ideal Seller’s Market
The ideal seller's market remains strong in 2022, and here is why business owners should consider selling their businesses.
What’s The Difference Between Recurring And Repeat Revenue?
If you are considering selling your business, you'll need to know the difference between recurring and repeat revenue as it can significantly impact the value of your business.
Benchmark International Successfully Facilitated the Transaction Between Real Regulatory Limited and Transcrip Partners LLP
tranScrip acquires Real Regulatory, significantly expanding tranScrip’s regulatory affairs capabilities, strengthening its ability to provide comprehensive support to its customers.
The New Reality and What it Means for Valuation
The bull market, like all markets, will end at some point. Understand the new normal of enhanced volatility and what it means for valuation of your business.
2022 Is a Seller's Year for M&A
Here is why 2022 is a better year to sell your business despite the success the record-breaking year of 2021.
2021 Was a Record Year For M&A - And 2022 Could be, Too
Take a look at why 2021 was a record year for M&A activity and learn what to expect for 2022.
Benchmark International Successfully Facilitated the Transaction Between CorEnergy Limited and Sureserve Group plc
Sureserve has acquired efficiency consultants CorEnergy for £7.5m in a deal facilitated by Benchmark International.
Benchmark International Successfully Facilitated the Transaction Between Coastal Retreats Limited & The Original Cottage Company Limited
Original Cottages has acquired Coastal Retreats in a deal facilitated by Benchmark International.
Benchmark International Successfully Facilitated the Transaction Between Southern Life Systems, Inc. and ADDvise
Benchmark International facilitated the transaction between Southern Life Systems, Inc. from Savannah, Georgia, and ADDvise, from Sweden, a leading supplier of equipment and services to healthcare and research facilities.